We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
-30.32%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$63.2M
AUM Growth
-$2.94B
(-98%)
Cap. Flow
-$2.92B
Cap. Flow
% of AUM
-4,611%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
705
New
–
Increased
–
Reduced
3
Closed
702
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$377M |
| 2 |
NVIDIA
NVDA
|
+$94.4M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$76.7M |
| 4 |
Amazon
AMZN
|
+$54.2M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 96.87% |
| 2 | Technology | 3.13% |
| 3 | Consumer Staples | 0% |
| 4 | Energy | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Qiagen
QGEN
$8.54B
| – | – |
-8,886
| Closed | -$407K |
|
|
502
Invesco QQQ Trust
QQQ
$453B
| – | – |
-150,000
| Closed | -$76.7M |
|
503
Ryder
R
$9.83B
| – | – |
-4,131
| Closed | -$648K |
|
504
Ultragenyx Pharmaceutical
RARE
$2.45B
| – | – |
-27,949
| Closed | -$1.18M |
|
505
RB Global
RBA
$20.4B
| – | – |
-14,738
| Closed | -$1.33M |
|
506
Regency Centers
REG
$14.7B
| – | – |
-57,995
| Closed | -$4.29M |
|
507
Regeneron Pharmaceuticals
REGN
$78.5B
| – | – |
-2,789
| Closed | -$1.99M |
|
508
Replimune Group
REPL
$941M
| – | – |
-172,202
| Closed | -$2.09M |
|
509
Rexford Industrial Realty
REXR
$8.42B
| – | – |
-55,519
| Closed | -$2.15M |
|
510
Reynolds Consumer Products
REYN
$5.26B
| – | – |
-22,072
| Closed | -$596K |
|
511
Royal Gold
RGLD
$16.8B
| – | – |
-63,339
| Closed | -$8.35M |
|
512
Robert Half
RHI
$3.87B
| – | – |
-25,297
| Closed | -$1.78M |
|
513
Rio Tinto
RIO
$158B
| – | – |
-306,116
| Closed | -$18M |
|
514
Riot Platforms
RIOT
$7.63B
| – | – |
-136,935
| Closed | -$1.4M |
|
515
Rithm Capital
RITM
$5.52B
| – | – |
-55,230
| Closed | -$598K |
|
516
Rocket Companies
RKT
$36.5B
| – | – |
-64,498
| Closed | -$726K |
|
517
Rambus
RMBS
$9.87B
| – | – |
-410,113
| Closed | -$21.7M |
|
518
ResMed
RMD
$30.6B
| – | – |
-3,034
| Closed | -$694K |
|
519
Rollins
ROL
$18.3B
| – | – |
-11,319
| Closed | -$525K |
|
520
Roper Technologies
ROP
$38.8B
| – | – |
-651
| Closed | -$338K |
|
521
Royalty Pharma
RPRX
$25.9B
| – | – |
-101,578
| Closed | -$2.59M |
|
522
Range Resources
RRC
$9.38B
| – | – |
-37,191
| Closed | -$1.34M |
|
523
Regal Rexnord
RRX
$13.7B
| – | – |
-45,219
| Closed | -$7.01M |
|
524
Rhythm Pharmaceuticals
RYTM
$6.81B
| – | – |
-25,062
| Closed | -$1.4M |
|
525
SentinelOne
S
$6.53B
| – | – |
-65,719
| Closed | -$1.46M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2025 Portfolio in Review
As of Q1 2025, Crestline Management held 705 positions worth $63.2M, down 98% from $3.01B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Crestline Management withdrew a net $2.92B in Q1 2025, closing 702 positions and reducing 3 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $377M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Staples.
- Crestline Management's biggest Q1 2025 reduction was Denali Therapeutics, cutting an estimated $2.87M.
- Crestline Management fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $377M.
- Crestline Management's ten largest holdings make up 100% of its $63.2M portfolio in Q1 2025.
- Crestline Management opened 0 new positions and closed 702 in Q1 2025.
- Crestline Management's portfolio value fell 98% quarter-over-quarter to $63.2M.
Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.